Core Capital Management & Research inc. has made a new investment of $5.53 million in Devon Energy Corporation (NYSE:DVN), acquiring 133,752 shares, making it their 10th largest holding. Analysts currently rate Devon Energy a "Moderate Buy" with a consensus price target of $59.23, following the company's recent beat on quarterly earnings and revenue expectations. Devon Energy also declared a quarterly dividend of $0.32 per share, representing a 2.6% annualized yield.

Proficio Capital Partners LLC has acquired 14,758 shares of International Business Machines Corporation (IBM) during the second quarter, valued at approximately $4.15 million. Institutional investors now collectively own 58.96% of IBM's outstanding stock. Despite meeting earnings expectations, IBM's revenue fell short of estimates, and the company recently announced a quarterly dividend of $1.69 per share.

Wellington Management Group LLP significantly reduced its stake in Chipotle Mexican Grill (NYSE:CMG) by 93.2% in the second quarter, selling 1.87 million shares. Despite this large sale, institutional ownership remains high at 91.3%, with major firms like BlackRock and Capital World Investors holding substantial positions. Analysts generally maintain a "Moderate Buy" rating for CMG, with an average price target of $43.84, following the company's slight outperformance in its recent quarterly earnings.

Core Capital Management & Research inc. recently acquired a significant new position in Kraft Heinz Company (NASDAQ:KHC) during the second quarter, purchasing 332,763 shares valued at approximately $8.52 million, making it their second-largest holding. Other institutional investors like BlackRock Inc. and California State Teachers Retirement System also increased their stakes. Despite analyst ratings like "Reduce" and an average price target of $23.33, the company announced a quarterly dividend of $0.40 per share, yielding 6.5%.

Wellington Management Group LLP increased its stake in Leidos Holdings, Inc. by 48.2% during the second quarter, acquiring an additional 12,034 shares, bringing its total holdings to 37,022 shares valued at $3,812,000. This institutional activity comes amidst other hedge funds also adjusting their positions in Leidos, and follows insider selling by company directors. The company recently reported strong quarterly earnings, exceeding analyst expectations, and announced a stock repurchase plan and a quarterly dividend.

Wellington Management Group LLP significantly increased its holdings in Willis Towers Watson Public Limited Company (NASDAQ:WTW) by 145.3% in the second quarter, bringing its total ownership to 16,504 shares valued at $4.31 million. Other institutional investors have also adjusted their positions, and hedge funds collectively own 93.09% of the company's stock. Analysts generally maintain a "Moderate Buy" rating for WTW, with an average target price of $369.38, following recent price target increases and rating upgrades.

HSBC downgraded Amgen (NASDAQ:AMGN) from Buy to Hold and lowered its price target due to valuation concerns, despite the stock being considered undervalued by InvestingPro analysis. While HSBC sees limited near-term upside due to a patent cliff and growth capping, the long-term thesis remains positive with Amgen's rare disease exposure and biosimilar portfolio. Recent developments include positive clinical trial results for a lung cancer treatment and an increase in price targets by other analysts, though a regulatory setback for a rare-disease drug was also noted.

Core Capital Management & Research inc. has purchased 12,122 shares of Archer Daniels Midland Company (NYSE:ADM) valued at approximately $973,000 during the second quarter. Archer Daniels Midland recently reported strong quarterly earnings, beating estimates with $1.84 per share, and declared a quarterly dividend of $0.52 per share. Institutional investors collectively own 78.28% of ADM's stock, and analysts currently have a consensus "Hold" rating with an average price target of $79.67.

Christian Rodseth of Johnson & Johnson Innovative Medicine emphasizes the critical need to accelerate patient access to new medicines in Korea, where authorization and reimbursement can take nearly four years. He highlights J&J's commitment to R&D and collaboration, citing the success of lazertinib as an example of Korean innovation reaching global patients. Rodseth commends recent Korean government initiatives, such as fast-track listing for rare diseases and flexible ICER approaches, as vital steps towards improving timely access and realizing the full societal and economic value of medical advancements.

Transamerica Financial Advisors LLC has taken a significant position in International Business Machines Corporation (IBM), purchasing 2,767 shares valued at $778,000 during the second quarter. This move is part of a broader trend of institutional investment in IBM, with 58.96% of the stock owned by institutional investors, including major firms like BlackRock Inc. and State Street Corp. Analyst sentiment for IBM remains a "Moderate Buy" with an average price target of $265.90, despite some recent price target adjustments and minimal insider ownership with a recent executive share sale.